Vanessa Kennedy
@vekennedy
Followers
301
Following
2K
Media
1
Statuses
71
Assistant Professor @StanfordMed | Myeloid Malignancies, Cellular Therapies
San Francisco, CA
Joined March 2009
RT @oncodaily: Excellent article with an overview of the first years of JCO Clinical Cancer Informatics - @ADesaiMD.@ASCO @ONealCancerUAB @….
0
3
0
RT @ASTCT_Journal: A 10-year study examining #cGVHD durability and immune reconstitution reveals sustained reduction in cGVHD rate and last….
0
5
0
RT @AbdulhaqHaifaa: Thank you to all our speakers and participants in making @btfoundation hematology and breast conference in Fresno a gre….
0
4
0
RT @atulbutte: Thrilled to announce our new @NEJM_AI article (!.Lead author @madhumitasushil worked with @TravisZac….
ai.nejm.org
Both medical care and observational studies in oncology require a thorough understanding of a patient’s disease progression and treatment history, often elaborately documented within clinical notes...
0
40
0
RT @UChicagoLeuk: We are excited to host and learn from Dr Vanessa Kennedy today at @UCCancerCenter Leukemia Research Seminar. @vekennedy @….
0
4
0
RT @Anand_88_Patel: Please join us on June 2nd at 1pm for the @ASCO #ASCO23 oral abstract session on leukemia, MDS & cell therapies! It's a….
0
9
0
RT @benhamner: Hiring core of ml/data/engineering team for our new co (w/ @antgoldbloom). DM if interested. Goal: Apply AI to build high qu….
0
8
0
RT @KellySchoenbeck: Congratulations to @UCSFCancer super 🌟@vekennedy on her amazing oral presentation at #ASH22 on single cell sequenc….
0
8
0
RT @TheBloodDoc: UCSF, the most photogenic crew!! @vekennedy @KelseyNatsuhara @mattfjones1 @corynnkasap @thehemeoncfellow and in absentia @….
0
5
0
RT @Anand_88_Patel: A very helpful paper in @BloodAdvances by @vekennedy et al outlining outcomes in mast cell leukemia #mpnsm #leusm .- m….
0
8
0
RT @ANCO_News: @vekennedy recipient of an ANCO sponsored ASCO YIA updating ANCO’s Board of Director’s on her project. .
0
1
0
RT @JCOCCI_ASCO: 🎉👋 Welcome to our new #JCOCCI Editorial Fellows! @Ben_A_Bates & @vekennedy will spend the next year getting a peek behind….
0
3
0
RT @FrontOncology: ⭐ #2: FLT3 Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging Controversies. 👨⚕️👩⚕️ @vekennedy & Catherine….
0
1
0
RT @bitafakhri: A fantastic write-up of a case of EBV-negative Aggressive NK-cell Leukemia (ANKL) and how genomics helped clarify the diagn….
0
4
0
Congrats @SwethaKMD— A wonderful physician doing amazing research! I’m lucky to call her a colleague!.
Big congrats to @SwethaKMD - she just got her first grant funded today!!! What a huge accomplishment and a great feeling - the first of many I’m sure! Privileged to work w her and @ninashah33 on this exciting clinical project to overcome daratumumab resistance in #myeloma.
1
0
3
👇🏼 Yes!.
My favorite tidbits (For mentees):.✔️Be a finisher. The only things that count are what you move to the "done pile". ✔️If an institution has a board of directors, why shouldn't you?. ✔️A good mentor teaches you skills that cross disciplines (don't be afraid to change direction).
0
0
4
RT @CNN: “It’s easier to be a parent this morning. It’s easier to be a dad. It’s easier to tell your kids character matters. It matters. Te….
0
14K
0
Great summary of a great talk! I learned so much!.
0
0
2
RT @AnaVManana: Great work by @annap_MD & mentors summarizing & understanding the rapidly evolving recommendations for #COVID19 coagulopath….
pmc.ncbi.nlm.nih.gov
As the Coronavirus disease 2019 (COVID-19) pandemic spread to the US, so too did descriptions of an associated coagulopathy and thrombotic complications. Hospitals created institutional protocols for...
0
2
0
170,000!.
6/ San Francisco continues to demonstrate what might have been. If the rest of the U.S. matched SF’s per capita death rate 170,000 dead Americans would be alive today. It's not rocket science: just strong leadership and people wearing masks & distancing.
0
0
1